Carpenter Technology (CRS) director reports option exercise and sale; ownership totals updated
Rhea-AI Filing Summary
Karol Steven E, a director of Carpenter Technology Corporation (CRS), reported transactions on 09/09/2025. The filing shows he exercised Director Stock Options with an exercise price of $34.76 to acquire 3,433 shares and simultaneously sold 3,433 shares at an average price of $245.7829 per share (individual sale prices ranged from $245.69 to $245.92). After these reported transactions the filing lists 180,000 shares directly owned by the reporting person and 228,881 shares held indirectly by affiliates. The option grant was under the companys Stock Based Compensation Plan for Non-Employee Directors and had an original grant date of 10/13/2016 with an expiration of 10/13/2025.
Positive
- Option exercise executed under the companys Stock Based Compensation Plan for Non-Employee Directors
- Sale prices explicitly reported with intra-day range ($245.69 to $245.92), providing transparent pricing for the sale
Negative
- None.
Insights
TL;DR: Director exercised options and sold the same number of shares, reducing direct holdings to 180,000 while affiliates hold 228,881.
The filing documents a routine director option exercise and contemporaneous sale of the resulting shares. The exercise price is explicitly stated at $34.76 and the reported average sale price is $245.7829, with individual trades between $245.69 and $245.92. Such transactions typically reflect liquidity events following option vesting; the report shows the reporting persons direct beneficial ownership at 180,000 shares and indirect ownership via affiliates at 228,881 shares. There is no disclosure here of additional material corporate developments.
TL;DR: This Form 4 records a non-employee directors option exercise and sale under the director compensation plan, reported in accordance with Section 16.
The disclosure notes the option was granted under the companys Stock Based Compensation Plan for Non-Employee Directors and shows exercise and sale on the same date. The filing includes required details: grant date (10/13/2016), expiration (10/13/2025), and transaction pricing. From a governance perspective, the filing appears to comply with Section 16 reporting requirements and does not disclose any departures or other governance actions.